The correct option is 1, 2 and 3 because the passage states that HMPV is well-studied and has a history of exposure, indicating more documentation compared to SARS-CoV-2 (1). It emphasizes the differences in virus families, symptom severity, and affected populations, leading to different outcomes (2), and highlights the differing long-term impacts, noting the absence of post-viral symptoms for HMPV (3). The statement about seasonal specificity is incorrect, as it notes strong seasonality in HMPV but does not imply a commonality with SARS-CoV-2.